News

/News
News2018-10-11T21:33:29+00:00

CONFORM Clinical trial poster

Efficacy, Safety, and Subject Satisfaction Using Rotational Fractional Resection for the Improvement of Submental Contouring. By Steve Dayan, MD; Jill Waibel, MD; Steve Yoelin, MD CONFORM clinical trial poster

Recros Medica Showcases Interim Data on Rotational Fractional Resection Technology at 2018 ASDS

SAN DIEGO, Oct. 9, 2018 /PRNewswire/ -- Recros Medica, Inc. announced today it will showcase its Rotational Fractional Resection (RFR) platform at the 2018 American Society for Dermatologic Surgery Annual Meeting. This investigational technology which is being developed as the Nuvellus™ Focal Contouring System for use by dermatologists, plastic surgeons and other aesthetic physicians to reduce skin laxity and remove Read more

Recros Medica Unveils the Nuvellus Brand for Its Novel Rotational Fractional Resection Technology

SAN DIEGO, CA, September 27, 2018 – Recros Medica, Inc., an aesthetic medical device company focused on developing devices to reduce skin laxity and improve focal contouring through its Rotational Fractional Resection platform technology, will unveil the Nuvellus brand at this week’s American Society of Plastic Surgery meeting. The company will display at booth #1264, where it will introduce Nuvellus Read more

Recros Medica Announces New Patent Issued by USPTO

SAN DIEGO, June 19, 2018 /PRNewswire/ -- Recros Medica, Inc., an aesthetic medical device company focused on developing devices to reduce skin laxity and improve focal contouring through its Rotational Fractional Resection platform technology, announced today that the US Patent and Trademark Office has issued a new patent for a system that includes an array of circular cutting instruments called scalpets.  The patent Read more

Recros Medica Closes $9M Financing, Strengthens Board

SAN DIEGO, CA, January 4, 2018 – Recros Medica, Inc., a development stage medical aesthetic device company focused on reducing skin laxity and focal contouring, announced today that it has closed a $9M financing. Additionally, the company is strengthening its Board of Directors with the additions of Christoph Westphal, MD, PhD and Mark Kerslake. “We are grateful for the additional Read more

Recros Medica Appoints Thomas A. Albright as President and CEO

SAN DIEGO, CA, September 18, 2017 – Recros Medica, Inc., a development stage medical aesthetic device company focused on reducing skin laxity and focal contouring, announced today that Thomas A. Albright has been named President and CEO, and will also serve on the Company’s Board of Directors. Mr. Albright brings nearly 35 years of healthcare experience to Recros Medica, with Read more

This website uses cookies and third party services. Ok